SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: BCAM International

14 Dec 2013 04:26 AM
06 Nov 1997 12:14 AM <--

Return to BCAM International
 
Here's a little gem of a stock that has a dynamic CEO determined to make this a 100 million dollar company. His goals are outlined in today's press release. Check it out.

BCAM International Inc. Appoints Kenneth C. Riscica Chief Financial Officer

November 5, 1997 01:25 PM

MELVILLE, N.Y., Nov. 5 /PRNewswire/ -- BCAM International Inc. BCAM announced today the appointment of Kenneth C. Riscica as its Vice President - Finance, Chief Financial Officer, Treasurer and Secretary.

Mr. Riscica formerly was a partner in charge of an emerging companies practice group with Arthur Andersen & Co. LLP, having been a partner from 1987 to 1992 (after joining the firm in 1976). More recently, Ken has served as Managing Director of Riscica Associates, Inc., a financial and management consultant firm and as Chief Financial Officer of Magna-Lab, Inc., a publicly traded medical technology company. "Ken joins the senior management team of BCAM at a critical turning point for the Company," said Michael Strauss, Chairman and Chief Executive Officer of BCAM. "My strategy to realize value for our shareholders involves three elements: (i) partnering with industry leaders for our Intelligent Surface Technology ("IST"), (ii) acquisition of stable complementary businesses and (iii) enhancing the potential for the proprietary "human factor engineering" software of our HumanCAD(R) Systems Division. In 1997 three critical elements of the plan came to fruition: (i) the first commercial application of IST was rolled out by Cadillac (the first intelligent auto seat), (ii) the acquisition of Drew Shoe, a $15 million manufacturer of medical footwear and (iii) the HumanCAD(R) Systems Division, which markets ergonomic (human factor) software for the PC, has relaunched ManneQuin PRO as its flagship product targeted at the Computer Aided Design (CAD) market and ManneQuinONSITE which provides architects, space designers and facility managers with scaleable, accurate human factors data.

"The future for BCAM now involves new acquisitions, related financing, cost management, integration of the businesses and financing the rollout of exciting new software products," said Mr. Strauss. "Ken brings extensive business experience in financing, mergers and acquisitions, change management, cost containment as well as financial planning and control. He will play a key role in helping me build value for BCAM's shareholders. I am delighted to have Ken on our team."

"Mike Strauss has reinvented BCAM," said Kenneth Riscica. "He has a very aggressive agenda to build the Company involving acquisitions in the medical footwear arena and the launch of a basket of high potential software products as well as incorporating BCAM's IST into several products. Making the acquisitions, financing the growth and managing for profitability are present opportunities for the Company. I am excited about the opportunity to help build value for the BCAM shareholders."

BCAM International Inc. is a software technology company, with operations in medical footwear manufacturing and distribution, ergonomic consulting and software and technology licensing.

Safe Harbor Statements under the Private Securities Litigation Reform Act of 1995. This announcement contains "forward-looking statements. The words "anticipate", "believe", "estimate", "expect" and other similar expressions as they relate to the Company and its management are intended to identify such forward-looking statements. Although the Company and its management believe that the statements contained in this announcement are reasonable, it can give no assurances that such statements will prove correct. Factors that could affect the occurrence of events or results discussed herein include those mentioned in the Company's Form 10-KSB. SOURCE BCAM International Inc.